[go: up one dir, main page]

CL2025000553A1 - Polymorphic form of estetrol and its production - Google Patents

Polymorphic form of estetrol and its production

Info

Publication number
CL2025000553A1
CL2025000553A1 CL2025000553A CL2025000553A CL2025000553A1 CL 2025000553 A1 CL2025000553 A1 CL 2025000553A1 CL 2025000553 A CL2025000553 A CL 2025000553A CL 2025000553 A CL2025000553 A CL 2025000553A CL 2025000553 A1 CL2025000553 A1 CL 2025000553A1
Authority
CL
Chile
Prior art keywords
estetrol
production
polymorphic form
preparing
pharmaceutical composition
Prior art date
Application number
CL2025000553A
Other languages
Spanish (es)
Inventor
Cornut Damien
DUHIRWE Gilbert
Original Assignee
Estetra Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Estetra Srl filed Critical Estetra Srl
Publication of CL2025000553A1 publication Critical patent/CL2025000553A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Estetrol monohidrato cristalino: proceso para prepararlo y composicion farmacéutica que lo comprende.Estetrol crystalline monohydrate: process for preparing it and pharmaceutical composition containing it.

CL2025000553A 2024-02-28 2025-02-27 Polymorphic form of estetrol and its production CL2025000553A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP24160281 2024-02-28

Publications (1)

Publication Number Publication Date
CL2025000553A1 true CL2025000553A1 (en) 2025-08-29

Family

ID=90105116

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2025000553A CL2025000553A1 (en) 2024-02-28 2025-02-27 Polymorphic form of estetrol and its production

Country Status (3)

Country Link
CL (1) CL2025000553A1 (en)
TW (1) TW202533830A (en)
WO (1) WO2025181200A1 (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9001895B2 (en) 2011-06-08 2015-04-07 Panasonic Intellectual Property Management Co., Ltd. Image display device and image processing device
SI2764008T1 (en) 2011-10-07 2016-10-28 Estetra S.P.R.L. Process for the production of estetrol
MA39105B1 (en) 2013-12-12 2018-05-31 Donesta Bioscience B V Orally disintegrating solid dosage unit containing a constituent estetrol
IT201900021879A1 (en) 2019-11-22 2021-05-22 Ind Chimica Srl PROCESS FOR THE PREPARATION OF (15α, 16α, 17β) -ESTRA-1,3,5 (10) -TRIENE-3,15,16,17-TETROL (ESTETROLE) AND INTERMEDIATES OF THIS PROCESS
CA3232558A1 (en) 2021-10-01 2023-04-06 Roberto Lenna Process for preparing (15alpha,16alpha,17 eta)-estra-1,3,5(10)-triene-3,15,16,17-tetrol (estetrol) monohydrate

Also Published As

Publication number Publication date
TW202533830A (en) 2025-09-01
WO2025181200A1 (en) 2025-09-04

Similar Documents

Publication Publication Date Title
ECSP22012347A (en) SUBSTITUTED 2-MORPHOLINOPYRIDINE DERIVATIVES AS ATR KINASE INHIBITORS
ECSP22058816A (en) SUBSTITUTED TRICYCLIC COMPOUNDS
ECSP22050936A (en) SUBSTITUTED TRICYCLIC COMPOUNDS
ECSP21034668A (en) DERIVATIVES OF 2,3-DIHYDRO-1H-PIRROLO [3,4-C] PYRIDIN-1-ONA AS INHIBITORS OF HPK1 FOR THE TREATMENT OF CANCER
CU20190086A7 (en) 6-6 FUSED BICYCLIC HETEROARYL COMPOUNDS USEFUL AS LATS INHIBITORS
AR032335A1 (en) TRIAZOLO COMPOUND POLYMORPH [4,5-D] PYRIMIDINE, A MIXTURE, PROCESS FOR PREPARATION, PHARMACEUTICAL COMPOSITION, AND USE OF THESE COMPOUNDS FOR THE MANUFACTURE OF MEDICINES
AR053412A1 (en) INHIBITING COMPOUNDS OF INTERACTION BETWEEN MDM2 AND P53, A METHOD OF PREPARATION, PHARMACEUTICAL COMPOSITION AND USE OF THE COMPOUND TO MANUFACTURE MEDICATIONS
PE20030612A1 (en) BENZOIMIDAZOLES
GT200500223A (en) RAPAMYCIN POLYMORPH II AND ITS USES
UY39517A (en) BTK INHIBITORS
EA201990688A1 (en) POLYMORPHIC FORMS OF COMPOUNDS REPRESENTING A KINASE INHIBITOR CONTAINING THEIR PHARMACEUTICAL COMPOSITION, METHOD FOR PRODUCING THEIR AND THEIR APPLICATION
BR112023015721A2 (en) TRICYCLIC DERIVATIVES USEFUL AS PARP7 INHIBITORS
PE20250676A1 (en) PI3K-ALPHA INHIBITORS AND METHODS FOR THEIR PRODUCTION AND USE
CL2025000672A1 (en) Aminopyrimidine derivatives, CDK2 inhibitors; pharmaceutical composition; use for treating cancer.
IL308071A (en) Process for the preparation of nlrp3 inhibitors
MX2023014722A (en) CRYSTALLINE FORM OF TOLEBRUTINIB AND METHOD OF PREPARATION AND ITS USE.
CL2025000553A1 (en) Polymorphic form of estetrol and its production
CL2025001257A1 (en) Process for the production of substituted morpholine derivatives
CL2023003921A1 (en) Transglutaminase inhibitors
EP4353230A3 (en) Solid state forms of asciminib and process for preparation thereof
CL2021001944A1 (en) Amino acid derivatives for the treatment of inflammatory diseases
CO2024000832A2 (en) Transglutaminase inhibitors
MX2016016339A (en) COMPOSITION COADYUVANTE OF A GROWTH FACTOR AND A NEUROPEPTIDE TO ACCELERATE THE WOUND CICATRIZATION AND THE ORGAN REPITELIZATION.
CL2023003979A1 (en) Transglutaminase inhibitors
MX2024007587A (en) Triazolone derivative salt as neutrophil elastase inhibitor.